Detection of glucose-6-phosphate dehydrogenase deficiency in the newborn using blood specimens dried on filter paper

APOBEC mutational signatures predict immune checkpoint inhibitor benefit in TMB-low metastatic NSCLC independent of PD-L1 status.

ESMO open·2026

Global advances and future directions in lung cancer care: expert consensus and strategic priorities.

ESMO open·2026

COMPEL: osimertinib plus platinum-based chemotherapy in patients with EGFR-mutated advanced NSCLC and progression on first-line osimertinib.

ESMO open·2025

Pemetrexed plus platinum with or without pembrolizumab in patients with previously untreated metastatic nonsquamous NSCLC: protocol-specified final analysis from KEYNOTE-189.

Annals of oncology : official journal of the European Society for Medical Oncology·2021

Clinical activity of brigatinib in ROS1-rearranged non-small cell lung cancer.

Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·2020